‘Text/HTML’ of page ‘NRG-HN009: Cisplatin and Radiation for Advanced Head and Neck Cancer’
Frequently Asked Questions Below, you can find FAQs about clinical research and this particular clinical trial.
Read MoreFrequently Asked Questions Below, you can find FAQs about clinical research and this particular clinical trial.
Read MoreAm I eligible for this study? If you over the age of 18 with advanced head and neck cancer, you may be able to participate. Your healthcare team is the best source for information about your treatment options, including cancer clinical trials. Be sure to take this information to your doctor to discuss your questions […]
Read MoreAbout This Study NRG-HN009 is a clinical study for patients who have advanced head and neck cancer. This study compares two schedules of the chemotherapy drug, cisplatin, given every three weeks versus every week with radiation for patients with this type of disease. The study has two parts: the first part of the study […]
Read MoreClinical Studies FAQ
Read MoreNRG-HN009 FAQ
Read More